Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quetiapine 25mg tablets
0402010ABAAABAB
|
Quetiapine | Quetiapine | Central Nervous System | 152,698 |
|
Quetiapine 100mg tablets
0402010ABAAACAC
|
Quetiapine | Quetiapine | Central Nervous System | 115,492 |
|
Quetiapine 200mg tablets
0402010ABAAADAD
|
Quetiapine | Quetiapine | Central Nervous System | 78,131 |
|
Quetiapine 300mg tablets
0402010ABAAAKAK
|
Quetiapine | Quetiapine | Central Nervous System | 69,609 |
|
Quetiapine 150mg tablets
0402010ABAAAFAF
|
Quetiapine | Quetiapine | Central Nervous System | 59,495 |
|
Quetiapine 50mg modified-release tablets
0402010ABAAAVAV
|
Quetiapine | Quetiapine | Central Nervous System | 26,196 |
|
Sondate XL 50mg tablets
0402010ABBCAAAV
|
Sondate | Quetiapine | Central Nervous System | 21,374 |
|
Sondate XL 300mg tablets
0402010ABBCACAX
|
Sondate | Quetiapine | Central Nervous System | 20,152 |
|
Quetiapine 300mg modified-release tablets
0402010ABAAAXAX
|
Quetiapine | Quetiapine | Central Nervous System | 19,668 |
|
Quetiapine 200mg modified-release tablets
0402010ABAAAWAW
|
Quetiapine | Quetiapine | Central Nervous System | 16,354 |
|
Sondate XL 200mg tablets
0402010ABBCABAW
|
Sondate | Quetiapine | Central Nervous System | 15,991 |
|
Sondate XL 400mg tablets
0402010ABBCADAY
|
Sondate | Quetiapine | Central Nervous System | 14,434 |
|
Quetiapine 50mg tablets
0402010ABAABHBH
|
Quetiapine | Quetiapine | Central Nervous System | 13,072 |
|
Quetiapine 150mg modified-release tablets
0402010ABAABABA
|
Quetiapine | Quetiapine | Central Nervous System | 10,127 |
|
Zaluron XL 300mg tablets
0402010ABBHADAX
|
Zaluron XL | Quetiapine | Central Nervous System | 10,095 |
|
Quetiapine 400mg modified-release tablets
0402010ABAAAYAY
|
Quetiapine | Quetiapine | Central Nervous System | 9,719 |
|
Zaluron XL 50mg tablets
0402010ABBHAAAV
|
Zaluron XL | Quetiapine | Central Nervous System | 9,502 |
|
Biquelle XL 50mg tablets
0402010ABBIAAAV
|
Biquelle XL | Quetiapine | Central Nervous System | 9,468 |
|
Sondate XL 150mg tablets
0402010ABBCAEBA
|
Sondate | Quetiapine | Central Nervous System | 9,457 |
|
Biquelle XL 300mg tablets
0402010ABBIADAX
|
Biquelle XL | Quetiapine | Central Nervous System | 8,674 |
|
Brancico XL 300mg tablets
0402010ABBLAAAX
|
Brancico XL | Quetiapine | Central Nervous System | 7,786 |
|
Brancico XL 50mg tablets
0402010ABBLADAV
|
Brancico XL | Quetiapine | Central Nervous System | 7,225 |
|
Biquelle XL 200mg tablets
0402010ABBIACAW
|
Biquelle XL | Quetiapine | Central Nervous System | 7,034 |
|
Zaluron XL 200mg tablets
0402010ABBHACAW
|
Zaluron XL | Quetiapine | Central Nervous System | 7,005 |
|
Zaluron XL 400mg tablets
0402010ABBHAEAY
|
Zaluron XL | Quetiapine | Central Nervous System | 6,775 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.